RecruitingNCT04792281
Impact of FDG-PET/CT on Management of Patients with Native Valve Infective Endocarditis
Sponsor
Montreal Heart Institute
Enrollment
97 participants
Start Date
Aug 31, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The proposed study is a multicentric prospective observational cohort study of patients with suspected NVE. The study population includes those with Possible IE according to the modified Duke criteria and investigated at one of the 6 participating sites which include 2 cardiac centers, the MHI and the IUCPQ, as well as 4 tertiary care centers, the Jewish General Hospital , the McGill University Health Centre and the CHUS.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- years of age or older, capable to provide informed consent;
- Referred for a FDG-PET/CT study
- Classified as having Possible IE prior to FDG-PET/CT imaging;
- Patients must be able to tolerate the physical/logistical requirements of a PET/CT scan.
Exclusion Criteria3
- Subjects with prosthetic cardiac valve and/or CIED;
- Pregnant or breastfeeding female;
- Body mass index > 45 kg/m2.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04792281
Related Trials
Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.
NCT067040481 location
CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.
NCT0626967910 locations
Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective Endocarditis
NCT054463761 location
Betalactam Pharmacokinetics in Endocarditis Patients
NCT046473314 locations
Echocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3
NCT064573861 location